
Nilvadipine Increases Bloodflow to Brain in Alzheimer’s
OFF-LABEL DRUGS, VIDEO & ARTICLE: The American Heart Association reports the blood pressure drug nilvadipine increases blood flow to the brain’s memory and learning center.
OFF-LABEL DRUGS, VIDEO & ARTICLE: The American Heart Association reports the blood pressure drug nilvadipine increases blood flow to the brain’s memory and learning center.
VIDEO + ARTICLE: A new imaging scan has revealed a culprit in the cognitive decline of Alzheimer’s. Find out more.
VIDEO: Researchers are exploring a therapy that involves the use of a surgically implanted device that delivers mild electrical pulses to specific areas of the
DIET & RESEARCH: Researchers have found that olive oil in the Mediterranean diet may hold the key to mitigating aging-related diseases — but the Mediterranean
GENETIC RESEARCH: Researchers at MIT studying the APOE4 gene are looking at choline supplements and asking whether they can offer protection against Alzheimer’s, based on
VIDEO + ARTICLE: Phase II/III trials are begining in the Tau NextGen study. The study will assess the effect of Lecanemab, an experimental anti-amyloid therapy,
VIDEO + ARTICLE Eliminating sensory loss due to cataracts — by removing the cataracts — could reduce one’s risk of developing dementia, according to research
Incredible images taken by the world’s largest synchrotron exposed a missing link in the early-Alzheimer’s cascade. They imply new drugs may do better stabilizing amyloid
VIDEO + ARTICLE: Using olive oil instead of mayonnaise, margarine and dairy fat such as butter can reduce your risk of developing a neurodegenerative disease
VIDEO: Researchers in the “90+” study find that one form of the so-called Alzheimer’s gene, ApoE-2, actually appears to protect the “oldest old” against the
Leqembi, the first Alzheimer’s-modifying drug, is a giant step forward—but how many people are getting it, and what does it really cost the average American? We dig into the numbers, the barriers, and the path forward.
VIDEO + ARTICLE:
Ergothioneine (ET) from mushrooms has been associated with brain health for years. In a six-year study, seniors consuming 300 grams of mushrooms weekly had 50% less risk of mild cognitive impairment (MCI, often referred to as pre-dementia). Get the facts about this correlation.
Getting in and out of a car’s passenger seat may not be simple, once dementia sets in. Learn the skills needed.
What are the early symptoms of Alzheimer’s? When to get a professional evaluation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
No spam, only news and updates.